PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable diagnosis of this tumor or prediction of therapeutic response...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Asuka, Hayashi, Tomoatsu, Shimizu, Naomi, Kobayashi, Mana, Taniue, Kenzui, Takahashi, Akiko, Tachibana, Kota, Saito, Misato, Kawabata, Ayako, Iida, Yasushi, Ueda, Kazu, Saito, Motoaki, Yanaihara, Nozomu, Tanabe, Hiroshi, Yamada, Kyosuke, Takano, Hirokuni, Nureki, Osamu, Okamoto, Aikou, Akiyama, Tetsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880602/
https://www.ncbi.nlm.nih.gov/pubmed/29632642
http://dx.doi.org/10.18632/oncotarget.24555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880602/
https://www.ncbi.nlm.nih.gov/pubmed/29632642
http://dx.doi.org/10.18632/oncotarget.24555

Ejemplares similares